Genetic modifiers in mice: the example of the fragile X mouse model
- PMID: 15237233
- DOI: 10.1159/000078218
Genetic modifiers in mice: the example of the fragile X mouse model
Abstract
Modifiers play an important role in most, if not all human diseases, and mouse models. For some disease models, such as the cystic fibrosis knockout mouse model, the effect of genetic factors other than the causative mutation has been well established and a modifier gene has been mapped. For other mouse models, including those of the fragile X syndrome, a common form of inherited mental retardation, controversies between test results obtained in different laboratories have been well recognized. Yet, the possibility that modifiers could at least explain part of the discrepancies is only scarcely mentioned. In this review we compare the test results obtained in different laboratories and provide evidence that modifiers may affect disease severity in the fragile X knockout mouse.
Copyright 2004 S. Karger AG, Basel
Similar articles
-
A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.Genes Brain Behav. 2004 Dec;3(6):337-59. doi: 10.1111/j.1601-183X.2004.00087.x. Genes Brain Behav. 2004. PMID: 15544577
-
Altered synaptic plasticity in a mouse model of fragile X mental retardation.Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50. doi: 10.1073/pnas.122205699. Proc Natl Acad Sci U S A. 2002. PMID: 12032354 Free PMC article.
-
Transgenic mouse model for the fragile X syndrome.Am J Med Genet. 1996 Aug 9;64(2):241-5. doi: 10.1002/(SICI)1096-8628(19960809)64:2<241::AID-AJMG1>3.0.CO;2-X. Am J Med Genet. 1996. PMID: 8844056
-
Fragile X syndrome, the Fragile X related proteins, and animal models.Microsc Res Tech. 2002 May 1;57(3):148-55. doi: 10.1002/jemt.10064. Microsc Res Tech. 2002. PMID: 12112450 Review.
-
Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008).Behav Neurosci. 2008 Apr;122(2):483-9. doi: 10.1037/0735-7044.122.2.483. Behav Neurosci. 2008. PMID: 18410188 Review.
Cited by
-
Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.Biol Psychiatry. 2014 Feb 1;75(3):198-206. doi: 10.1016/j.biopsych.2013.08.003. Epub 2013 Sep 13. Biol Psychiatry. 2014. PMID: 24041505 Free PMC article.
-
Targeted Treatments for Fragile X Syndrome.Adv Neurobiol. 2023;30:225-253. doi: 10.1007/978-3-031-21054-9_10. Adv Neurobiol. 2023. PMID: 36928853
-
Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice.J Physiol. 2009 Feb 15;587(Pt 4):787-804. doi: 10.1113/jphysiol.2008.160929. Epub 2008 Dec 22. J Physiol. 2009. PMID: 19103683 Free PMC article.
-
Utility of the Hebb-Williams Maze Paradigm for Translational Research in Fragile X Syndrome: A Direct Comparison of Mice and Humans.Front Mol Neurosci. 2018 Mar 28;11:99. doi: 10.3389/fnmol.2018.00099. eCollection 2018. Front Mol Neurosci. 2018. PMID: 29643767 Free PMC article.
-
Disruption of Foxg1 expression by knock-in of cre recombinase: effects on the development of the mouse telencephalon.Neuroscience. 2007 Aug 24;148(2):385-99. doi: 10.1016/j.neuroscience.2007.06.012. Epub 2007 Jul 19. Neuroscience. 2007. PMID: 17640820 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical